Dr. Gary Volkell
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- New York Medical College (2016)
- Years since graduation
- 10
- In the NPI registry since
- 2016
- Medicare patients seen, 2024
- 472
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2016Medical school: New York Medical College
- 2016Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
NY license 302718 -
Student in an Organized Health Care Education/Training Program
NY license 63816
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Medstar Franklin Square Medical Center Rosedale, MD
- Medstar Good Samaritan Hospital Baltimore, MD
Medical groups
- Medstar Medical Group II LLC (3,767 clinicians)
- Medstar Total Elder Care, LLC (27 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 472
- Services billed
- 16,891
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 11,050 | 24 |
| Established patient office or other outpatient visit, 40-54 minutes | 369 | 225 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 106 | 91 |
| New patient office or other outpatient visit, 60-74 minutes | 61 | 61 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 58 | 23 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 53 | 20 |
| Injection of chemical for paralysis of nerve muscles on trunk, 1-5 muscles | 47 | 19 |
| Established patient office or other outpatient visit, 30-39 minutes | 37 | 34 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 35 | 34 |
| Telephone medical discussion with physician, 5-10 minutes | 29 | 21 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Albany, NY | 281 |
| Primidone Other prescribers in Albany, NY | 142 |
| Carbidopa-Levodopa Er (carbidopa/levodopa) Other prescribers in Albany, NY | 136 |
| Memantine Hcl Other prescribers in Albany, NY | 114 |
| Propranolol Hcl Er (propranolol hcl) Other prescribers in Albany, NY | 110 |
| Gabapentin Other prescribers in Albany, NY | 108 |
| Donepezil Hcl Other prescribers in Albany, NY | 94 |
| Clonazepam Other prescribers in Albany, NY | 57 |
| Escitalopram Oxalate Other prescribers in Albany, NY | 51 |
| Levetiracetam Other prescribers in Albany, NY | 45 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 14 companies reported 61 payments worth $2,394 in total to this clinician.
| Ipsen Innovation | $909 |
|---|---|
| AbbVie Inc. | $242 |
| Eisai Inc. | $223 |
| Amneal Pharmaceuticals LLC | $220 |
| Biogen, Inc. | $203 |
| Supernus Pharmaceuticals, Inc. | $186 |
| Neurocrine Biosciences, Inc. | $159 |
| Genentech USA, Inc. | $58.00 |
| Food and Beverage | $1,781 |
|---|---|
| Travel and Lodging | $613 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Ipsen Innovation Jun 18, 2025 | Travel and Lodging travel to Minneapolis, MN · in-kind | $308 |
| Ipsen Innovation Jun 17, 2025 | Travel and Lodging travel to Minneapolis, MN · in-kind | $236 |
| Ipsen Innovation Jun 20, 2025 | Travel and Lodging travel to Minneapolis, MN · in-kind | $69.48 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $507 in research payments for these studies, mostly to the institutions running them.
- A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
Ipsen Innovation · Active, not recruiting · NCT06625060
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.